BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, March 19, 2024
Home
»
Newsletters
» BioWorld
BioWorld
Oct. 16, 2002
View Archived Issues
Overdose Of Acetaminophen (Tylenol) Results In Hundreds Of Ruined Livers Each Year
Read More
Xerion, Arius Team Up On Effort To Develop Colon Cancer Drugs
Read More
Other News To Note
Read More
Waksal Pleads Guilty To Six Charges Related To Erbitux
Read More
Invitrogen Paying $47M In Cash For Software Provider InforMax
Invitrogen Corp. aims to create a "desktop to lab bench" tool set with its buyout of InforMax Inc. in an all-cash transaction valued at $1.36 per share, or about $42 million for the fully diluted equity. (BioWorld Today)
Read More
European Officials Seek Unity To Help Challenge U.S. Position
Read More